Adverse selection

Adverse selection

The vendor and the buyer should both enter a transaction with an equal level of knowledge. The term “adverse selection” describes a situation in which the buyer or the seller knows a component of product quality that the other party does not. Comprehending adverse selection if you work in insurance, economics, or a similar field is critical because it could impact your transactions. 

 

What is adverse selection? 

A situation in which sellers know that buyers do not, or vice versa, regarding a certain feature of product quality. is referred to as adverse selection. So, those who work in hazardous environments or lead high-risk lives are more likely to buy life or disability insurance, knowing they will likely be able to use it.  

Moreover, a seller may be more knowledgeable than a consumer about the goods and services being supplied, which would disadvantage the buyer in the deal. Adverse selection may be seen in markets for insurance or used cars. 

Understanding adverse selection  

Adverse selection occurs when one party to a transaction has more precise knowledge than the other. The side with more information will profit more from the deal, which disadvantages the other party with less accurate information. The price charged for particular goods or services is inefficient due to information asymmetry. These circumstances might happen in the insurance industry, the capital market, and regular marketplaces.  

Insurers have discovered that high-risk individuals are more apt to purchase policies and make heftier premium payments in the insurance industry. The business suffers a financial loss by disbursing more benefits if it charges a low price but only high-risk customers purchase. Yet, the company has more money to pay such benefits because high-risk policyholders pay higher premiums.  

A life insurance provider, for instance, raises premiums for race car drivers. Residents of high-crime areas who get auto insurance from a company are charged more. Similarly, a health insurance provider sets higher premiums for some customers. 

Consequence of adverse selection  

Depending on the circumstance, adverse selection may harm buyers and sellers. It may lead to differences in how a good or service is valued, impacting transactions. For instance, if a seller conceals a product problem from the buyer despite being aware of it, the buyer may end up with a product that falls short of his needs or expectations.  

The seller may have difficulties since potential customers can decide not to buy if they can’t discern the real value of a good or service. Adverse selection can have significant market effects in the insurance industry. High-risk purchasers who hide information to obtain lower premiums might cause a company to face serious financial problems.  

As a result, fewer insurance providers will be in the market, which raises costs for low-risk customers. Ultimately, adverse selection may result in a market with fewer options and higher rates for low-risk consumers. 

Adverse selection between buyer and seller  

When a buyer plans to acquire a service or good from a seller, but the seller knows more about the good or service, this is known as adverse selection. The buyer is disadvantaged in this scenario since he is entering into a contract with a seller who might not be prepared to disclose all the details regarding the offered object. 

 

Adverse selection in the capital markets  

Some securities are more vulnerable to adverse selection than others in the capital markets. For instance, a fast-growing business might charge a premium price for equity when selling it to investors in the capital markets. The investor is subjected to adverse selection if the capital market managers possess inside knowledge about the company that outside investors are unaware of. 

Frequently Asked Questions

Due to the information asymmetry in the market caused by customers’ lack of access to the seller or producer-held information, adverse selection drives up costs. While consumers may be cautious about the quality of the goods offered for sale, this may also result in lower consumption. 

Adverse selection occurs when the pool of potential customers or employees from which a company must choose is not representative of the population as a whole. This can lead to a situation where the company is unable to accurately assess the risks and rewards associated with a given customer or employee, leading to suboptimal outcomes for both the company and the individual.  

In the context of insurance, for example, adverse selection can lead to a situation where sick people are more likely to buy insurance than healthy people, leading to higher premiums and a death spiral for the insurance company. 

The lemon problem, which asserts that used car buyers can’t tell the difference between a nice used automobile (a peach) and a lousy used car (a lemon), leads them to pay the average of the two while hoping for the best, is the most famous example of adverse selection. 

There are a few potential solutions to adverse selection in markets. One is to have better information available to buyers and sellers. Additionally, insurance companies restrict coverage or raise prices to reduce exposure to major claims.  

For example, if people are buying health insurance, there could be a requirement that everyone purchase a basic level of coverage. This would help to ensure that people are not choosing insurance plans that only cover the healthiest individuals. 

It is also possible to directly address the problem of adverse selection through regulation. For example, the government could impose minimum standards on insurance plans or set up a risk classification system to help ensure that people are not choosing policies that do not meet their needs. 

Moral hazard mostly affects transactions before they happen. After a transaction, adverse selection is mostly a problem. Asymmetry in information leads to moral hazard. Moral hazard is eliminated when adverse selection is eliminated. 

 

 

Grouping high-risk persons and charging them greater fees are one-way insurance firms  might avoid adverse selection. 

Related Terms

    Read the Latest Market Journal

    Weekly Updates 26/2/24 – 1/3/24

    Published on Feb 28, 2024 47 

    This weekly update is designed to help you stay informed and relate economic and company...

    All-in-One Guide to Investing in China via ETFs

    Published on Feb 27, 2024 271 

    Start trading on POEMS! Open a free account here! Why China? In the vast landscape...

    Navigating the Post-Inflation Landscape in 2024: Top 10 US Markets Key Events to Look out for

    Published on Feb 23, 2024 310 

    Start trading on POEMS! Open a free account here! In 2023, the United States experienced...

    From Boom to Bust: Lessons from the Barings Bank Collapse

    Published on Feb 23, 2024 60 

    Barings Bank was one of the oldest merchant banks in England with a long history...

    Decoding FX CFD 2.0

    Published on Feb 20, 2024 66 

    This article is aimed at availing information and knowledge essential to intermediate forex traders. It...

    Weekly Updates 19/2/24 – 23/2/24

    Published on Feb 19, 2024 89 

    This weekly update is designed to help you stay informed and relate economic and company...

    Unlock Prosperity with 5 Sure-Fire Financial Instruments!

    Published on Feb 14, 2024 197 

    In Singapore, the concept of guaranteed returns may evoke the spirit of prosperity, reminiscent perhaps...

    Weekly Updates 12/2/24 –16/2/24

    Published on Feb 13, 2024 70 

    This weekly update is designed to help you stay informed and relate economic and company...

    Contact us to Open an Account

    Need Assistance? Share your Details and we’ll get back to you

    IMPORTANT INFORMATION

    This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

    An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

    Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

    Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

    The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

    The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

    The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

    This advertisement has not been reviewed by the Monetary Authority of Singapore.  

     

    Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
    250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
    Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com